CD8A and breast cancer: Our study extends these observations by demonstrating the independent prognostic impact of higher CD8+ density in the IZ tumor aspect in the context of pathology indicators (Table 4, model 3) and conventional BC IHC data (Table 4, model 4), and further supplemented by the Ki67-ITH indicator (Table 4, model 5).